AIM
AMED

Acrospire Investment Management’s Amedisys AMED Stock Holding History

Acrospire Investment Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,333
Closed -$84K – 63
2017
Q2 		$84K Buy
1,333
+700
+111% +$40.8K 0.08% 352
2017
Q1 		$32K Buy
+633
New +$30.2K 0.03% 1311
2016
Q4 		– Sell
-733
Closed -$35K – 2173
2016
Q3 		$35K Sell
733
-900
-55% -$44.9K 0.02% 1259
2016
Q2 		$82K Sell
1,633
-600
-27% -$30.3K 0.06% 636
2016
Q1 		$108K Buy
+2,233
New +$86.2K 0.07% 275

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Acrospire Investment Management's AMED Position: Q3 2017 in Review

Acrospire Investment Management sold out of Amedisys (AMED) in Q3 2017, closing a stake of 1,333 shares — an estimated $84K sold.

Acrospire Investment Management first reported a position in AMED in Q1 2016 and held it in 5 quarters. The position peaked at $108K in Q1 2016. 163 funds tracked by Wall St. Rank hold AMED as of Q3 2017.

  • Acrospire Investment Management reported no remaining Amedisys position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,333 Amedisys shares in Q3 2017, an estimated $84K.
  • Acrospire Investment Management first reported a position in Amedisys in Q1 2016 and held it in 5 quarters.
  • Acrospire Investment Management's Amedisys position peaked at $108K in Q1 2016.
  • 163 funds tracked by Wall St. Rank held Amedisys as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.